Office of the Inspector General

Audit of Global Fund Grants in Mozambique

11 March 2022

Mozambique has made significant progress in fighting HIV, tuberculosis (TB) and malaria. Malaria deaths fell by 70% between 2015 and 2019, TB coverage increased by 46% between 2015 and 2020, and antiretroviral enrolment increased from 42% in 2015 to 68% in 2020. However, improvement is needed in a number of areas, such as low antiretroviral retention, weak monitoring of patients who are lost to follow-up, low viral load coverage and suppression, and programs for key and vulnerable populations.

The supply chain is fragmented and managed by several stakeholders, with diluted accountability and ownership. There are a lack of basic controls related to inventory management, warehousing, and logistics data accuracy, and stock-outs and expiries are impacting services to patients.

Mozambique had utilized less than 35% of its available COVID-19 2020 funding by the end of the grant (June 2021). The low absorption and use of COVID-19 funding could hamper future preparedness as well as programmatic progress.